|
Where do you start when developing a new medicine?
|
27 March 2014 |
|
GSK increases stake in Indian Pharmaceuticals subsidiary to 75 %
|
10 March 2014 |
|
Tafinlar® receives FDA Breakthrough Therapy designation for non-small cell lung cancer with BRAF mutation
|
14 January 2014 |
|
GSK adds detailed clinical trial data to multi-sponsor request system
|
06 January 2014 |
|
GSK responds to FDA decision on Avandia (rosiglitazone)
|
27 November 2013 |
|
H5N1 vaccine approved by the U.S. FDA as pandemic influenza preparedness measure
|
25 November 2013 |
|
Five inspirational organisations from Malawi, Bangladesh, Mali, Kenya, and Colombia recognised by GSK and Save the Children
|
18 November 2013 |
|
GSK names inaugural winners in unique competition for academic drug hunters
|
10 November 2013 |
|
New partnership between GSK and the Bill & Melinda Gates Foundation to accelerate research into vaccines for global health needs
|
31 October 2013 |
|
GSK and Genmab announce submission to US regulatory authorities for Arzerra® (ofatumumab)
|
20 October 2013 |